Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (1): 130-133    DOI: 10.31083/j.ejgo.2020.01.4777
Case Report Previous articles | Next articles
Negative p53 expression and negative high risk HPV in a 26-year-old lady with vulvar keratinizing squamous cell carcinoma: report of a case
M.H. Hajeer1, *(), A. Al Khader2, N.A. Shahin1, M.S. Bata1
1 Jordan University Hospital, Jordan University, Amman, Jordan
2 Department of Basic Medical Sciences, Faculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan
Download:  PDF(883KB)  ( 333 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Vulvar intraepithelial neoplasia (VIN) and human papilloma virus (HPV) are the main pathways for development of vulvar carcinoma in young women. While, non-HPV associated pathway is the usual pattern seen in postmenopausal women. Herein, the authors report a case of 26-year-old lady with keratinizing vulvar squamous cell carcinoma (SCC), in which vulvar intraepithelial neoplasia (VIN) of the simplex type and p53 expression were absent. Moreover, no high risk HPV was detected by the highly sensitive real time-polymerase chain reaction (RT-PCR) technology on the paraffin embedded tumor tissue. Therefore, in addition to the patient's young age, she had morphologic and molecular patterns that are usually seen in elderly women. The authors believe that this is an unusual presentation in such a very young lady. The cause of this cancer in this case is not completely understood and indicates the necessity to sample any sus- picious lesions at this site at any age.
Key words:  Juvenile vulvar carcinoma      Human papilloma virus      Juvenile keratinizing squamous cell carcinoma      Polymerase chain reaction      Immunohistochemistry     
Published:  15 February 2020     
*Corresponding Author(s):  M.H. HAJEER     E-mail:  m.hajeer83@hotmail.com; m.hajeer@ju.edu.jo

Cite this article: 

M.H. Hajeer, A. Al Khader, N.A. Shahin, M.S. Bata. Negative p53 expression and negative high risk HPV in a 26-year-old lady with vulvar keratinizing squamous cell carcinoma: report of a case. European Journal of Gynaecological Oncology, 2020, 41(1): 130-133.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.01.4777     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I1/130

[1] Jaudah Al-Maghrabi, Haneen Al-Maghrabi. SIRT1 is overexpressed in endometrial adenocarcinoma: a tissue microarray analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 699-704.
[2] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[3] Qunying Wu, Jin-Ho Kuk, Young-Joon Ryu. A Distinct Human Papilloma Virus Epidemiological Profile of Korean-Chinese Women Living in Yanbian, China[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 753-761.
[4] Hyang Sook Jeong, Yuki Gen, Hui Ryun Joo, Ji Geun Yoo, Seung Geun Yeo, Dong Choon Park. Mesonephric-like carcinoma of the uterine corpus: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 664-667.
[5] Soo-Young Lee, Dae-Hyung Lee. Perivascular epithelioid cell tumor arising in the left parametrium: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 657-660.
[6] Sung-Im Do, Hee-Chul Shin, Hee Sung Kim. Clinical significance of MET receptor protein and mRNA expression in invasive breast cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 240-245.
[7] Y. S. Lee, J. M. Baek, E. K. Park, C. J. Kim, H. J. Lee, J. O. Kim. Expression and therapeutic potential of macrophage migration inhibitory factor and CD74 in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 65-69.
[8] N. K. Šuster, M. Meznaric, N. Škorja, I. Virant-Klun, I. Verdenik, Š. Smrkolj. Cancer stem cell-related marker NANOG expression in ovarian serous tumors using Western blotting and immunohistochemistry: comparison of two techniques[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 948-952.
[9] Yangyang Shi, Yongyun Shi, Dabao Wu. A case of placental site trophoblastic tumor and a retrospective analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1096-1099.
[10] H. Ibrahim, K. Dresser, K. M. Cornejo. Loss of 5-hydroxymethylcytosine (5-hmC) expression in endometrioid type endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 846-848.
[11] A.M. Sindiani, M.S. Alorjani, B.K. Aldaraiseh. Dysgerminoma of the ovary in an adolescent girl associated with a high serum β-human chorionic gonadotropin (β-hCG) level[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 859-861.
[12] S. Kabukcuoglu, B. Hayit. Histopathologic features of advanced stage endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 614-618.
[13] Lan Zhong, Feng Deng, Xingsheng Shu, Zhilan Peng. P53 overexpression predicts unfavorable prognosis of low risk endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 463-467.
[14] H. Matsushita, H. Yabushita, T. Tsuzuki, A. Wakatsuki. Squamous cell carcinoma of the endometrium with contiguous superficial spreading to the vagina, uterine cervix, fallopian tube, and ovary[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 487-489.
[15] H. Cao, S. Yang, S. Xie, M. Xi. The association between p16INK4a and prognosis in endometrial carcinoma: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 311-317.
No Suggested Reading articles found!